Amedisys Inc. buy Royal Bank of Canada
Start price
25.03.24
/
50%
€84.00
Target price
25.03.25
€92.26
Performance (%)
-0.60%
Price
25.04.24
€83.50
Summary
This prediction is currently active. Since the start of the prediction for Amedisys Inc. the price has only changed by -0.60%. This prediction currently runs until 25.03.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amedisys Inc. | 0.000% | 0.000% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for AMED provided by MarketBeat